Archive by Tag: cancer

A Legacy of Innovation: The Max Noureddine Exit Interview, Part One

Prateek Peres-da-Silva, an intern at Thought Leader Select and student at the University of North Carolina’s Kenan-Flagler Business School, recently sat down with Dr. Maher “Max” Noureddine, Thought Leader Select’s departing chief scientific officer, to discuss his achievements at the[...]

The Thought Leaders Driving Thought Leader Select: A Blog Series—Dr. Maher Noureddine

Dr. Maher “Max” Noureddine joined Thought Leader Select as its chief scientific officer in 2007, after a two-year stint as a senior research fellow in molecular genetics at the National Institute of Environmental Health Sciences/National Institutes of Health (NIEHS/NIH). Prior[...]

US Prescription Sales Up in 2009; Top Therapy Areas Reflected in Thought Leader Select Projects

IMS Health reports a 5.1 percent increase in U.S. prescription sales in 2009. Demand for prescription drugs (new therapies and refills) as well as new treatment options for cancer, thrombosis and atrial fibrillation, and new generic treatment options drove growth[...]